Search Within

Thoracic Oncology

Formats
  1. Meeting Abstract (1709)
  2. Journal Article (1439)
  3. Review (82)
  4. Editorial (58)
  5. Book Section (35)
  6. Guidelines (25)
  7. Conference Paper (21)
  8. Correspondence (10)
  9. Research Letter (7)
  10. Miscellaneous (6)
  11. Book Whole (2)
Groups
  1. Department of Medicine (3394)
  2. Solid Tumor Oncology Division (3394)
  3. GSK Faculty (1071)
  4. Department of Pathology and Laboratory Medicine (809)
  5. Center for Molecular Imaging and Biotechnology (CMIB) (662)
  6. Human Oncology and Pathogenesis Program (635)

More Groups

People
  1. Mark Kris (872)
  2. Alexander Drilon (637)
  3. Gregory Riely (605)
  4. Charles Rudin (495)
  5. Marc Ladanyi (418)
  6. Matthew Hellmann (412)

More People

Years
  1. 2025 (114)
  2. 2024 (271)
  3. 2023 (273)
  4. 2022 (337)
  5. 2021 (337)
  6. 2020 (258)

More Years

Publications
  1. Journal of Clinical Oncology (703)
  2. Journal of Thoracic Oncology (517)
  3. Annals of Oncology (278)
  4. Clinical Cancer Research (158)
  5. Cancer Research (128)
  6. International Journal of Radiation Oncology, Biology, Physics (89)

More Publications

Publishers
  1. American Society of Clinical Oncology (782)
  2. Elsevier Inc. (738)
  3. American Association for Cancer Research (386)
  4. Oxford University Press (352)
  5. Nature Publishing Group (156)
  6. Elsevier Science, Inc. (79)

More Publishers

Results (3394)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Concurrent mutations in STK11 and KEAP1 is associated with resistance to PD-(L)1 blockade in patients with NSCLC despite high TMB
    Meeting Abstract

    Arbour, K.; Shen, R.; Plodkowski, A.; Rizvi, H.; Ni, A.; Long, N.; Halpenny, D.; Sanchez-Vega, F.; Rudin, C.; Riely, G.; more...
    Journal of Thoracic Oncology (2018)

    Fulltext@MSK | Save
  • PARP inhibitor radiosensitization of small cell lung cancer differs by PARP trapping potency
    Meeting Abstract

    Lok, B.; Laird, J.; Ma, J.; De Stanchina, E.; Poirier, J.; Rudin, C.
    Journal of Thoracic Oncology (2018)

    Fulltext@MSK | Save
  • CNS activity of ramucirumab in combination with osimertinib in patients with advanced T790M-positive EGFR-mutant NSCLC
    Meeting Abstract

    Paz-Ares, L.; Planchard, D.; Yang, J. C.; Lee, K.; Garrido, P.; Park, K.; Kim, J.; Lee, D. H.; Mao, H.; Chao, B.; more...
    Journal of Thoracic Oncology (2018)

    Fulltext@MSK | Save
  • Long-term outcomes with first-line nivolumab plus ipilimumab in advanced NSCLC: 3-year follow-up from CheckMate 012
    Meeting Abstract

    Antonia, S.; Gettinger, S.; Borghaei, H.; Goldman, J. W.; Brahmer, J.; Ready, N.; Gerber, D.; Chow, L.; Juergens, R.; Laurie, S.; more...
    Journal of Thoracic Oncology (2018)

    Fulltext@MSK | Save
  • gC1qR expression is independently prognostic for survival benefit following chemotherapy in mesothelioma
    Meeting Abstract

    Li, X.; Eguchi, T.; Aly, R.; Chintala, N.; Tan, K. S.; Messinger, J.; Zauderer, M.; Ghebrehiwet, B.; Adusumilli, P.; Peerschke, E.
    Journal of Thoracic Oncology (2018)

    Fulltext@MSK | Save
  • Long-term safety and clinical activity results from a phase Ib study of erlotinib plus atezolizumab in advanced NSCLC
    Meeting Abstract

    Rudin, C.; Cervantes, A.; Dowlati, A.; Besse, B.; Ma, B.; Costa, D.; Schmid, P.; Heist, R.; Villaflor, V.; Sarkar, I.; more...
    Journal of Thoracic Oncology (2018)

    Fulltext@MSK | Save
  • Clinical and molecular characteristics of EGFR mutant lung cancers with concurrent TP53 and RB1 mutations
    Meeting Abstract

    Offin, M.; Tenet, M.; Shen, R.; Rekhtman, N.; Rizvi, H.; Hellmann, M.; Arcila, M.; Ladanyi, M.; Rudin, C.; Kris, M.; more...
    Journal of Thoracic Oncology (2018)

    Fulltext@MSK | Save
  • Efficacy and genomic correlates of response to anti-PD1/PD-L1 blockade in non-small cell lung cancers harboring targetable oncogenes
    Meeting Abstract

    Vokes, N.; Jimenez Alguilar, E.; Adeni, A.; Umeton, R.; Sholl, L.; Rizvi, H.; Hellmann, M.; Awad, M.; Van Allen, E.
    Journal of Thoracic Oncology (2018)

    Fulltext@MSK | Save
  • Comprehensive peripheral blood immunophenotyping and T-cell clonal analysis during neoadjuvant immunotherapy with atezolizumab in NSCLC
    Meeting Abstract

    Oezkan, F.; He, K.; Owen, D.; Pietrzak, M.; Kitzler, R.; Pearson, R.; Nicholas, A.; Bunn, P. Jr; Kris, M.; Kwiatkowski, D.; more...
    Journal of Thoracic Oncology (2018)

    Fulltext@MSK | Save
  • Neoadjuvant atezolizumab in resectable non-small cell lung cancer (NSCLC): Updated results from a multicenter study (LCMC3)
    Meeting Abstract

    Rusch, V.; Chaft, J.; Johnson, B.; Wistuba, I.; Kris, M.; Lee, J.; Bunn, P. Jr; Kwiatkowski, D.; Reckamp, K.; Finley, D.; more...
    Journal of Thoracic Oncology (2018)

    Fulltext@MSK | Save